NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

At the Annual Meeting if almost nothing new is provided, I believe there is one bit of information that could be provided that would tell us a great deal, in fact I believe it could be sufficient to move the stock up dramatically. That bit of information is, how many patients are currently alive in the trial.

I believe even a number as low as 40 is saying our vaccine is a game changer, but I think the number could very well be 60 or more, which clearly would be huge. Clearly I'm not one that believes in all the FDA's acceptance criterias, I believe in what I can clearly see. All anyone needs to know is that with over 300 GBM patients treated over more than a decade, the last of which were done roughly 4.5 years ago, with SOC treatment perhaps 15 would have been anticipated to be alive. Our trial may have four or more times that many, how can anyone deny a tremendous benefit when using our vaccine.

I certainly hope we hear more than this at the Annual Meeting, but if there were only one thing we learned, I hope it would be that one.

Gary